Content Details
Information on this page was last modified on : 2024/06/10 7:53:36 PM

PADCEV (enfortumab vedotin-ejfv) for injection

Belongs to Category

How It Works

PADCEV works by targeting a protein called Nectin-4, which is highly expressed in urothelial cancers. Enfortumab vedotin, the active ingredient in PADCEV, binds to Nectin-4 and delivers a potent chemotherapy drug directly to cancer cells. This targeted approach helps to kill cancer cells while minimizing damage to healthy tissues.

Side Effects

  • Fatigue
  • Nausea
  • Decreased appetite
  • Diarrhea
  • Peripheral neuropathy (numbness or tingling in the hands or feet)
  • Increased blood sugar levels


  • PADCEV is indicated for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have previously received a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor, and platinum-containing chemotherapy in the neoadjuvant/adjuvant, locally advanced or metastatic setting.


  • Hypersensitivity to enfortumab vedotin-ejfv or any of the excipients
  • Severe renal impairment (creatinine clearance less than 30 mL/min)
  • Pregnancy or breastfeeding

Price Comparison in Different Countries

Country Price (USD) Reference
United States $17,000.00 GoodRx
United Kingdom £14,000.00 NHS UK
Australia $20,000.00 AUD Pharmaceutical Benefits Scheme Australia
Canada $18,000.00 CAD MedBroadcast Canada

Top 5 Global Brands

  1. Astellas Pharma
  2. Pfizer
  3. Roche
  4. Bristol Myers Squibb
  5. Merck & Co.


Additional Information:

One of the following licensed pharmacy from the nearest location will deliver PADCEV (enfortumab vedotin-ejfv) for injection. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

Want to share this information?
Something doesn't feel right ?

Questions and Answers

There are no questions yet. Be the first to ask a question about this product.

Only registered users are eligible to enter questions


There are no reviews yet.

Be the first to review “PADCEV (enfortumab vedotin-ejfv) for injection”
Shopping Cart